Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 9/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 4/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 4/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.34 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.34 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25323660 | 0.95 | PRMT5 (0.39) | PRMT5WDR77TP53MDM2RIPK1 | |
| SCHEMBL25323662 | 0.95 | PRMT5 (0.39) | PRMT5WDR77TP53MDM2RIPK1 | |
| SCHEMBL25322165 | 0.92 | PRMT5 (0.36) | PRMT5WDR77TP53MDM2RIPK1 | |
| SCHEMBL30551045 | 0.92 | PRMT5 (0.36) | PRMT5WDR77TP53MDM2RIPK1 | |
| SCHEMBL30551629 | 0.86 | PRMT5 (0.40) | PRMT5WDR77 | |
| SCHEMBL25322224 | 0.86 | PRMT5 (0.40) | PRMT5WDR77 | |
| SCHEMBL30551659 | 0.86 | PRMT5 (0.47) | PRMT5WDR77RIPK1FFAR2 | |
| SCHEMBL25923592 | 0.86 | PRMT5 (0.47) | PRMT5WDR77RIPK1FFAR2 | |
| SCHEMBL25323600 | 0.86 | PRMT5 (0.47) | PRMT5WDR77RIPK1FFAR2 | |
| SCHEMBL25320105 | 0.85 | PRMT5 (0.35) | PRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4469455-A1 | COMPOUNDS AND METHODS OF USE | Tango Therapeutics, Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| WO-2023146990-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |